Literature DB >> 20133913

Protein S-nitrosylation and cardioprotection.

Junhui Sun1, Elizabeth Murphy.   

Abstract

Nitric oxide (NO) plays an important role in the regulation of cardiovascular function. In addition to the classic NO activation of the cGMP-dependent pathway, NO can also regulate cell function through protein S-nitrosylation, a redox dependent, thiol-based, reversible posttranslational protein modification that involves attachment of an NO moiety to a nucleophilic protein sulfhydryl group. There are emerging data suggesting that S-nitrosylation of proteins plays an important role in cardioprotection. Protein S-nitrosylation not only leads to changes in protein structure and function but also prevents these thiol(s) from further irreversible oxidative/nitrosative modification. A better understanding of the mechanism regulating protein S-nitrosylation and its role in cardioprotection will provide us new therapeutic opportunities and targets for interventions in cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133913      PMCID: PMC3137884          DOI: 10.1161/CIRCRESAHA.109.209452

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  154 in total

1.  Mitochondrial nitric oxide synthase.

Authors:  Paul S Brookes
Journal:  Mitochondrion       Date:  2004-03       Impact factor: 4.160

Review 2.  Regulation and specificity of S-nitrosylation and denitrosylation.

Authors:  Steven R Tannenbaum; Forest M White
Journal:  ACS Chem Biol       Date:  2006-11-21       Impact factor: 5.100

3.  No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine.

Authors:  H Post; R Schulz; M Behrends; P Gres; C Umschlag; G Heusch
Journal:  J Mol Cell Cardiol       Date:  2000-05       Impact factor: 5.000

Review 4.  PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

Authors:  M M Mocanu; D M Yellon
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

Review 5.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Authors:  Péter Ferdinandy; Richard Schulz
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

Review 6.  Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research.

Authors:  R Bolli
Journal:  J Mol Cell Cardiol       Date:  2001-11       Impact factor: 5.000

7.  S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.

Authors:  Jianguo Fang; Tomohiro Nakamura; Dong-Hyung Cho; Zezong Gu; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

8.  Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage.

Authors:  Andrew Webb; Richard Bond; Peter McLean; Rakesh Uppal; Nigel Benjamin; Amrita Ahluwalia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

9.  Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues.

Authors:  Seyed Isaac Hashemy; Arne Holmgren
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

Review 10.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

View more
  93 in total

Review 1.  Routes for formation of S-nitrosothiols in blood.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

2.  Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.

Authors:  Tiffany T Nguyen; Mark V Stevens; Mark Kohr; Charles Steenbergen; Michael N Sack; Elizabeth Murphy
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 3.  Mechanism of cardioprotection: what can we learn from females?

Authors:  Elizabeth Murphy; Claudia Lagranha; Anne Deschamps; Mark Kohr; Tiffany Nguyen; Renee Wong; Junhui Sun; Charles Steenbergen
Journal:  Pediatr Cardiol       Date:  2011-01-29       Impact factor: 1.655

4.  Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function.

Authors:  Farideh Beigi; Daniel R Gonzalez; Khalid M Minhas; Qi-An Sun; Matthew W Foster; Shakil A Khan; Adriana V Treuer; Raul A Dulce; Robert W Harrison; Roberto M Saraiva; Courtney Premer; Ivonne Hernandez Schulman; Jonathan S Stamler; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-24       Impact factor: 11.205

Review 5.  Redox modification of cell signaling in the cardiovascular system.

Authors:  Dan Shao; Shin-ichi Oka; Christopher D Brady; Judith Haendeler; Philip Eaton; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2011-09-17       Impact factor: 5.000

Review 6.  What can we learn about cardioprotection from the cardiac mitochondrial proteome?

Authors:  Marjan Gucek; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2010-08-30       Impact factor: 10.787

7.  Site-mapping of in vitro S-nitrosation in cardiac mitochondria: implications for cardioprotection.

Authors:  Christopher I Murray; Lesley A Kane; Helge Uhrigshardt; Sheng-Bing Wang; Jennifer E Van Eyk
Journal:  Mol Cell Proteomics       Date:  2010-10-29       Impact factor: 5.911

8.  Additive cardioprotection by pharmacological postconditioning with hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation.

Authors:  Junhui Sun; Angel M Aponte; Sara Menazza; Marjan Gucek; Charles Steenbergen; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2016-02-17       Impact factor: 10.787

Review 9.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system.

Authors:  Heaseung S Chung; Sheng-Bing Wang; Vidya Venkatraman; Christopher I Murray; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 10.  Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors:  Andrew M Walters; George A Porter; Paul S Brookes
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.